Planning

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)

Leeds Teaching Hospitals NHS Trust

This public procurement record has 2 releases in its history.

Planning

23 Sep 2026 at 12:50

UK2 - Preliminary Market Engagement Notice
Planning

23 Sep 2026 at 12:42

UK1 - Pipeline Notice
Summary of the contracting process

Leeds Teaching Hospitals NHS Trust, through the North East and Yorkshire NHS Pharmaceutical Purchasing Consortium, plans to buy a defined range of unlicensed imported medicines for NHS organisations and other eligible public bodies. The products are licensed in their country of origin but do not hold a UK Marketing Authorisation; they are intended for cases where a patient’s clinical needs cannot be met by a suitable licensed alternative. The supply may include medicines requiring over-labelling and translation. This is a pharmaceutical products procurement, covering supply to participating public-sector organisations across the UK. The framework is intended to give those organisations access to safe, quality-assured medicines and support continuity of patient care and supply-chain resilience.

The procurement is at planning stage: the buyer has stated its intention to establish a framework, and there is no invitation to tender yet. The expected route is a competitive flexible procedure. Previous preliminary market engagement was completed on 5 May 2026; the buyer considers it remains relevant following the change from a planned dynamic market to a framework, and currently plans no further separate engagement. A future notice is expected on 12 October 2026. The framework is planned to run from 1 May 2027 to 31 December 2028, with possible extension to 31 December 2029. The estimated value is £36,095,686.53 excluding VAT (£43,314,823.84 including VAT). The procurement is planned as a single lot.

This requirement is likely to suit medicines importers, pharmaceutical wholesalers and suppliers with the regulatory and operational capacity to import, distribute and supply unlicensed medicines in the UK. Suppliers will need the relevant MHRA licences, authorisations and approvals, and must demonstrate compliance with applicable Good Manufacturing Practice and Good Distribution Practice standards. Capability to provide products requiring over-labelling or translation may be relevant to the defined product range. The buyer intends to assess products and suppliers comprehensively for quality, risk and commercial factors, with the stated aims of regulatory compliance, resilient supply, continuity of patient care and value for money across the NHS. Small and medium-sized businesses are identified as suitable, as are voluntary, community and social enterprises.

How relevant is this notice?

Notice Information

Notice Title

NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)

Notice Description

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a framework agreement for the supply of Unlicensed Imported Medicines on behalf of NHS organisations and other eligible public sector bodies. The framework will provide access to a defined range of unlicensed imported medicines, including products requiring over-labelling and translation. These medicines do not hold a UK Marketing Authorisation but are licensed in their country of origin and may be imported and supplied in accordance with Regulation 167 of the Human Medicines Regulations 2012 where a patient's clinical needs cannot be met by a suitable licensed alternative. Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK, and to demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. The framework will provide participating organisations with access to safe, compliant and quality-assured products through a robust and competitive procurement arrangement. Products and suppliers will be subject to comprehensive quality, risk and commercial assessment to support regulatory compliance, supply chain resilience, continuity of patient care and value for money across the NHS.

Planning Information

Preliminary market engagement relating to this requirement was previously undertaken and notified under PME Notice Reference 2026/S 000-037341 in connection with the originally proposed Dynamic Market procurement route. The requirement, scope and anticipated market offering remain materially unchanged from those previously communicated to the market. The principal change is the decision to procure the requirement through a Framework Agreement rather than a Dynamic Market. As the Consortium considers that the previous engagement remains relevant and adequate in informing the procurement approach, no further separate programme of preliminary market engagement is currently proposed. This Preliminary Market Engagement Notice is therefore published to ensure transparency regarding the revised procurement strategy and to notify the market of the change in route.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07788b
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/090112-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Competitive flexible procedure
Tender Suitability
SME, VCSE
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£36,095,686 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
23 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
12 Oct 20265 days to go
Award Date
Not specified
Contract Period
1 May 2027 - 31 Dec 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Leeds Teaching Hospitals NHS Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 3EX
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...